Snakebite envenomings are a serious public health problem that affects large sectors of the populations in Latin America, Africa, Asia and Oceania. It is calculated that every year an average of 2.5 million people are bitten by snakes, resulting in 85,000 deaths and 250,000 people with some kind of permanent physical damage. The most affected groups are agricultural workers and children in rural areas of developing countries.

The Clodomiro Picado Institute is a leading institution in the research and development of antivenoms that benefit many countries in the Central American region, as well as the Caribbean, South America, and Africa. 

Antivenoms are the only type of medicinal product approved to treat snakebite envenomings. These products are of hospital use only, and should be administered as soon as possible to stop the effects of the venom. Antivenoms are specific for one or several types of venoms that need to be neutralized, which means that the product needs to be used in the specific regions where these snakes are found. 

Check our list of distributors: